Catalyst Wire Dossier Catalyst Wire Dossier

MAPI

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAPI, covering 2020-05-19 to 2020-05-19. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma [Phase 2]

See pricing